NovaBridge Biosciences: eps_diluted
| Value | {"per": "shares", "amount": -1.96, "concept": "us-gaap:EarningsPerShareDiluted", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | NovaBridge Biosciences |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f1d4c556-8db9-4dda-9fa0-8bd91780be51
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000950170-25-050344Retrieved: 2026-08-19T18:00:48.227251+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001778016/eps-diluted/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f1d4c556-8db9-4dda-9fa0-8bd91780be51
History
- supersedes {"per": "shares", "amount": -1.92, "concept": "us-gaap:EarningsPerShareDiluted", "currency": "USD"} (evidence 0001104659-23-053462)